Skip to main content

Federal Health Minister Rona Ambrose will meet with victims of the drug thalidomide on Monday to hear their recommendations for new government support.

Adrian Wyld/THE CANADIAN PRESS

Federal Health Minister Rona Ambrose will meet with victims of the drug thalidomide on Monday to hear their recommendations for new government support.

The meeting comes months after an organization representing thalidomide survivors began r‎equesting an audience with Ms. Ambrose. She has said she did not know of their request before The Globe and Mail detailed their plight in a Nov. 22 report.

Her office told The Globe last week that the survivors' request was forwarded to the department and not to the minister.

Story continues below advertisement

A spokesman for Ms. Ambrose said Sunday that the minister is looking forward to the meeting. "Our government is committed to supporting them and the Minister will be sitting down with them tomorrow to see how we can do exactly that," Michael Bolkenius said in a statement.

Asked what options might be under consideration, Mr. Bolkenius said the minister did not want to pre-empt survivors' demands and intended to hear directly from them before determining what Ottawa might offer.

Thalidomide was used to treat expectant mothers for symptoms such as morning sickness and was deemed safe by the government at the time of its use. It caused birth defects in nearly 100 people born in the early 1960s, such as flipper-like hands, stunted legs and internal organ damage.

Ms. Ambrose has said her department ‎is working on options for providing survivors with financial support.

The House of Commons is expected to approve a motion on Monday calling for "full support" for victims of thalidomide.‎ The Thalidomide Victims Association of Canada has said it would like a single lump-sum payment of $250,000 a victim for "urgent" needs, as well as annual support for the remainder of victims' lives. The association wants the sums to range from $75,000 to $150,000 a year, depending on the degree of the person's disability.

Report an error Editorial code of conduct
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter